Explore how DSS Inc’s blockchain, renewable, and packaging businesses keep investors focused amid media confusion from a Nigerian agency sharing its name.
Explore DSS Inc’s silent market stance: a $1 share, negative P/E, and $8.9 M cap amid industry diversity—what this means for investors seeking clarity.
A publicly traded company called DSS, Inc. is facing brand confusion due to its shared acronym with the Nigerian Department of State Services, an intelligence agency embroiled in controversy, despite being a separate entity with no operational overl…
DSS, Inc.’s subsidiary, Impact BioMedical Inc., has merged with global pharmaceutical company Dr. Ashleys Limited, creating a new publicly traded entity with enhanced capabilities in the biohealth innovation sector.
DSS Inc is a multifaceted leader in the industrials sector, operating across various sectors and positioning itself for future growth through innovation, sustainability, and strategic market expansion.